| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |